Home Researchers/Supervisors Gbolahan Ajibola

Researchers/Supervisors

Gbolahan Ajibola

SANTHE Path-to-Independence Awardee


Botswana Harvard Health Partnership (BHP),
Gaborone, Botswana

Gbolahan Ajibola is a Clinical Researcher at the Botswana Harvard Health Partnership (BHP) in Gaborone, Botswana, dedicated to addressing the paediatric HIV epidemic. He holds an MBBS, MPH and MSc, combining clinical expertise with public health and methodological training to support impactful research in HIV treatment and cure strategies.

His work includes leading pivotal clinical trials that have informed global HIV treatment guidelines, including the Early Infant Treatment (EIT) Study, which pioneered initiating antiretroviral therapy within the first week of life. This approach significantly reduced viral reservoir formation and established a high-quality cohort for cure-related research.

He is currently focused on achieving antiretroviral therapy–free remission in children and serves as Study Vice-Chair for the IMPAACT 2042/Tatelo Plus trial, which investigates broadly neutralising antibodies as a non-daily intervention to achieve post-treatment viral control in paediatric populations. His overarching goal is to translate scientific advances generated in Botswana into improved global clinical practice, contributing to the vision of an AIDS-free generation.

Publications
Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study Predictive Markers for Sustained Viral Suppression on Dual Broadly Neutralizing Antibodies During Antiretroviral Treatment Interruption in Children Antibody interventions in HIV: broadly neutralizing mAbs in children Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana

SANTHE is a pan-African consortium, with the Africa Health Research Institute (AHRI) serving as the operational site lead and funded by the Science for Africa Foundation through the DELTAS Africa programme; the Gates Foundation; Gilead Sciences Inc.; Aidsfonds; and the Ragon Institute of Mass General, MIT, and Harvard.

Copyright 2026 by SANTHE. All Rights Reserved.

Site by